Skip to main content

Artificial Intelligence in Agriculture Market Segmentation, Future Business Strategy 2020-2026


Precision agriculture encompasses several technologies such as guidance technologies, sensing technologies, analytics, and other precision technologies that reduce the misutilization of agri-inputs and enable efficient farming with profitability. The introduction of precision agriculture technologies has also resulted in the creation of hundreds of thousands of data points on farms. The rise in these data points has enabled data-driven farming, aiding the growers and consumers of agriculture products with insight-backed decision-making. However, the abundance of these data points has also left the agriculture industry plagued with massive amounts of data. To navigate through these big data in farms and to attain efficient farming solutions, the industry is bringing about significant product innovations in farm data analysis using artificial intelligence technology.

Artificial intelligence technology brings the concept of cognitive computing to agriculture, where the farm equipment intelligence is modeled on human intelligence. The capabilities enabled by this technology allow the farm equipment and solutions to interpret, acquire, and react to unpredictable farm situations with enhanced efficiency. Artificial intelligence technologies help farmers in optimizing their planning to generate profitable crop yields using predictable analytics for agri-input choices and farm process planning. For instance, AI technology has found use cases in crop disease detection, crop growth assessment, and crop yield prediction, preventing the over-application of fertilizers and other agri-inputs. The forecast of results for these agricultural processes in the market is powered by AI sensors and imaging equipment. The presence of these AI-based software and hardware products and services in the agriculture market has led to an optimistic growth of the precision agriculture market.

Although artificial intelligence technology has led to excitement in the whole industry, for agricultural AI players to quickly adopt the same and survive in the market, understanding the driving and restraint factors of the market is crucial.

The upcoming trend of artificial intelligence technology is not only prevalent in developed countries; developing countries have realized its importance as well. The upcoming trend of the use of artificial intelligence in agriculture has gained prevalence amongst the government of developed and developing countries.  The governments of these countries have also realized the need and advantages of this technology, and thus their initiatives to promote AI is expected to further drive the growth of artificial intelligence in agriculture market. 

However, there are certain challenges that prove to be a restraint in the growth of global artificial intelligence in agriculture market. The awareness and knowledge about newer technological advancements in the agriculture technologies such as artificial intelligence are yet to spread extensively amongst the growers, especially amongst those of the emerging countries. The lack of technical infrastructure in agriculture of developing countries and data privacy concerns among growers also act as a restraint in the market.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...